Provalis PLC - Re Directorate
09 Mars 2000 - 8:30AM
UK Regulatory
RNS Number:9389G
Provalis PLC
9 March 2000
PROVALIS APPOINTS CHRISTINE SODEN AS NEW NON-EXECUTIVE DIRECTOR
Provalis (LSE.PRO) is pleased to today announce the appointment
of Ms Christine Soden as a Non-Executive Director and as Chairman
of its Audit Committee. Ms Soden (42), a Chartered Accountant,
was formally the Finance Director of Chiroscience Group plc and,
following its merger with Celltech plc, Chief Financial Officer
of Celltech Chiroscience plc.
Mr Frank Harding, Non-Executive Chairman of Provalis, said: "I
welcome Christine Soden's appointment to the Board and her taking
up of the Chairmanship of Provalis' Audit Committee. Her
experience as a Finance Director with Chiroscience, and the roles
she has played in business development and investor relations,
are particularly relevant to Provalis at this time".
Provalis' Internet Website - http://www.provalis.com
"Safe Harbor" Statement under the US Private Securities
Litigation Reform Act of 1995: Some or all of the statements in
this document that relate to future plans, expectations, events,
performances and the like are forward looking statements as
defined in the US Private Securities Litigation Reform Act of
1995. Actual results of events could differ materially from those
described in the forward looking statements due to a variety of
factors, including those set forth in Provalis plc's filings with
the US Securities and Exchange Commission.
For further information:-
Mr Lee Greenbury, Provalis plc, Tel: 01244 833402
Lisa Baderoon, Buchanans Communications, Tel: 020 7466 5000
NOTES TO EDITORS
Ms Soden qualified as a Chartered Accountant in 1981. She was the
Group Financial Controller and Head of tax and treasury at Medeva
plc from 1991 until 1995 and played a key role in its
international corporate acquisition and fund raising programme.
She joined Chiroscience Group plc as its Finance Director in
January 1996 with responsibility for capital raising, mergers and
acquisitions, financial control, company secretarial and investor
relations. She also had significant roles in business development
and legal matters. She became the Chief Financial Officer of
Celltech Chiroscience plc following the merger of Chiroscience
Group plc and Celltech plc in August 1999. She has served on a
number of industry and governmental bodies and committees,
including serving as Chair of the Finance and Taxation Committee
of the BioIndustry Association and sitting on the Williams
Committee, which advised the government on matters relating to
the financing of high tech companies.
END
BOABLGDXLUGGGGI
Globaldata (LSE:DATA)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Globaldata (LSE:DATA)
Graphique Historique de l'Action
De Août 2023 à Août 2024